These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

850 related items for PubMed ID: 17936059

  • 21. Enhanced virtual screening by combined use of two docking methods: getting the most on a limited budget.
    Maiorov V, Sheridan RP.
    J Chem Inf Model; 2005; 45(4):1017-23. PubMed ID: 16045296
    [Abstract] [Full Text] [Related]

  • 22. Virtual compound screening in drug discovery.
    Stumpfe D, Ripphausen P, Bajorath J.
    Future Med Chem; 2012 Apr; 4(5):593-602. PubMed ID: 22458679
    [Abstract] [Full Text] [Related]

  • 23. Structure-based virtual screening protocols.
    Good A.
    Curr Opin Drug Discov Devel; 2001 May; 4(3):301-7. PubMed ID: 11560062
    [Abstract] [Full Text] [Related]

  • 24. Structure-based pharmacophore design and virtual screening for novel angiotensin converting enzyme 2 inhibitors.
    Rella M, Rushworth CA, Guy JL, Turner AJ, Langer T, Jackson RM.
    J Chem Inf Model; 2006 May; 46(2):708-16. PubMed ID: 16563001
    [Abstract] [Full Text] [Related]

  • 25. Towards improving compound selection in structure-based virtual screening.
    Waszkowycz B.
    Drug Discov Today; 2008 Mar; 13(5-6):219-26. PubMed ID: 18342797
    [Abstract] [Full Text] [Related]

  • 26. Affinity selection-mass spectrometry screening techniques for small molecule drug discovery.
    Annis DA, Nickbarg E, Yang X, Ziebell MR, Whitehurst CE.
    Curr Opin Chem Biol; 2007 Oct; 11(5):518-26. PubMed ID: 17931956
    [Abstract] [Full Text] [Related]

  • 27. Virtual screening for lead discovery.
    Tang YT, Marshall GR.
    Methods Mol Biol; 2011 Oct; 716():1-22. PubMed ID: 21318897
    [Abstract] [Full Text] [Related]

  • 28. SeleX-CS: a new consensus scoring algorithm for hit discovery and lead optimization.
    Bar-Haim S, Aharon A, Ben-Moshe T, Marantz Y, Senderowitz H.
    J Chem Inf Model; 2009 Mar; 49(3):623-33. PubMed ID: 19231809
    [Abstract] [Full Text] [Related]

  • 29. A novel in silico approach to drug discovery via computational intelligence.
    Hecht D, Fogel GB.
    J Chem Inf Model; 2009 Apr; 49(4):1105-21. PubMed ID: 19348414
    [Abstract] [Full Text] [Related]

  • 30. Alternative global goodness metrics and sensitivity analysis: heuristics to check the robustness of conclusions from studies comparing virtual screening methods.
    Sheridan RP.
    J Chem Inf Model; 2008 Feb; 48(2):426-33. PubMed ID: 18247505
    [Abstract] [Full Text] [Related]

  • 31. Selection criteria for drug-like compounds.
    Muegge I.
    Med Res Rev; 2003 May; 23(3):302-21. PubMed ID: 12647312
    [Abstract] [Full Text] [Related]

  • 32. Novel statistical approach for primary high-throughput screening hit selection.
    Yan SF, Asatryan H, Li J, Zhou Y.
    J Chem Inf Model; 2005 May; 45(6):1784-90. PubMed ID: 16309285
    [Abstract] [Full Text] [Related]

  • 33. Discovery of potent thermolysin inhibitors using structure based virtual screening and binding assays.
    Khan MT, Fuskevåg OM, Sylte I.
    J Med Chem; 2009 Jan 08; 52(1):48-61. PubMed ID: 19072688
    [Abstract] [Full Text] [Related]

  • 34. Considerations in compound database preparation--"hidden" impact on virtual screening results.
    Knox AJ, Meegan MJ, Carta G, Lloyd DG.
    J Chem Inf Model; 2005 Jan 08; 45(6):1908-19. PubMed ID: 16309298
    [Abstract] [Full Text] [Related]

  • 35. Smart screening: approaches to efficient HTS.
    Engels MF, Venkatarangan P.
    Curr Opin Drug Discov Devel; 2001 May 08; 4(3):275-83. PubMed ID: 11560058
    [Abstract] [Full Text] [Related]

  • 36. Virtual screening to enrich hit lists from high-throughput screening: a case study on small-molecule inhibitors of angiogenin.
    Jenkins JL, Kao RY, Shapiro R.
    Proteins; 2003 Jan 01; 50(1):81-93. PubMed ID: 12471601
    [Abstract] [Full Text] [Related]

  • 37. A kinase-focused compound collection: compilation and screening strategy.
    Sun D, Chuaqui C, Deng Z, Bowes S, Chin D, Singh J, Cullen P, Hankins G, Lee WC, Donnelly J, Friedman J, Josiah S.
    Chem Biol Drug Des; 2006 Jun 01; 67(6):385-94. PubMed ID: 16882313
    [Abstract] [Full Text] [Related]

  • 38. High-throughput assays for promiscuous inhibitors.
    Feng BY, Shelat A, Doman TN, Guy RK, Shoichet BK.
    Nat Chem Biol; 2005 Aug 01; 1(3):146-8. PubMed ID: 16408018
    [Abstract] [Full Text] [Related]

  • 39. Discovery of novel HIV entry inhibitors for the CXCR4 receptor by prospective virtual screening.
    Pérez-Nueno VI, Pettersson S, Ritchie DW, Borrell JI, Teixidó J.
    J Chem Inf Model; 2009 Apr 01; 49(4):810-23. PubMed ID: 19358515
    [Abstract] [Full Text] [Related]

  • 40. Optimization of high throughput virtual screening by combining shape-matching and docking methods.
    Lee HS, Choi J, Kufareva I, Abagyan R, Filikov A, Yang Y, Yoon S.
    J Chem Inf Model; 2008 Mar 01; 48(3):489-97. PubMed ID: 18302357
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 43.